Saudi Arabia's Capital Market Authority has approved BaraSeen Medical Company's application to register and offer 3,300,000 shares, representing 17.10% of its share capital, on the Parallel Market. The offering will be limited to Qualified Investors as defined in the Capital Market Authority's regulations and rules. A prospectus will be published sufficiently in advance of the offering. The authority said its approval means the application met the legal requirements under the Capital Market Law and its Implementing Regulations, and does not constitute a recommendation to invest. The approval remains valid for six months from the board resolution date. It will be cancelled if the offering and listing of the company's shares are not completed within that period.
Saudi Arabia Capital Markets Authority2026-06-25
Saudi Arabia's Capital Market Authority approves BaraSeen Medical Company Parallel Market offering of 3.3 million shares
Saudi Arabia's Capital Market Authority approved BaraSeen Medical Company's application to offer 3.3 million shares, equal to 17.10% of its share capital, on the Parallel Market. The sale is limited to Qualified Investors, with a prospectus to be published before the offering. Approval is valid for six months from the board resolution date and lapses if the offering and listing are not completed in that time.